α-SMA had been reported in the previous literature to be highly expressed in TNBC and luminal A breast cancer [3], but FAP expression in some kinds of breast cancer is low, so α-SMA as maker for CAFs is feasible. This evidence concerns the gene ACTA1 and breast carcinoma.